
Cingulate Inc.
CING·NASDAQ
Last updated as of 2026-07-06 12:25 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
CING stock price change
On the last trading day, CING stock closed at 5.38 USD, with a price change of -8.66% for the day.
Trade spot stocks (24/7)Bitget's stock quote pages provide comprehensive information on CING stock, including real-time prices, historical price charts, key data, price performance analysis, daily briefings, analyst forecasts, the latest news, business overviews, and financial analysis—all in one place. You can access real-time stock price information for Cingulate Inc. (CING), including 24-hour price movements, historical price charts, 52-week high and low ranges, market capitalization, trading volume, and key financial metrics such as price-to-earnings ratio, quarterly revenue, and earnings per share. You can also stay up to date on Cingulate Inc.'s stock price outlook and latest developments through analyst consensus price targets and curated news coverage. Information sources include NASDAQ stock exchange data, TradingView data, Cingulate Inc. financial reports, analysis from leading Wall Street institutions and analysts, and articles from major financial media outlets.
CING key data
Previous close5.38 USD
Market cap72.46M USD
Volume378.20K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-4.26 USD
Net income (FY)−22.45M USD
Revenue (FY)0.00 USD
Next report dateAug 18, 2026
EPS estimate-
Revenue estimate-
Shares float11.03M
Beta (1Y)−0.53

Bitget ushers in the Stocks 2.0 era:
A new way to trade stocks — anytime, anywhere, 24/7.
Access Wall Street liquidity, dividend payouts, and futures margin support.
Learn moreCingulate Inc. overview
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
Shane J. Schaffer
Headquarters
Kansas City
Website
cingulate.com
Founded
2012
Employees (FY)
14
Change (1Y)
+1 +7.69%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
−1.60M USD
CING stock price forecast
According to technical indicators for CING stock, the price is likely to fluctuate within the range of 5.89–6.40 USD over the next week. Market analysts predict that the price of CING stock will likely fluctuate within the range of 5.65–6.98 USD over the next months.
Based on 1-year price forecasts from 20 analysts, the highest estimate is 10.02 USD, while the lowest estimate is 4.74 USD.
For more information, please see the
CING stock price forecast
page.
Trending stocks
Trade spot stocks on Bitget
Trade stock perps on Bitget
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn moreLatest CING stock news
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Finviz2026-03-18 12:03:49
Cingulate Inc has submitted a prospectus supplement to the U.S. Securities and Exchange Commission, planning to conduct a market offering and sell common shares in phases for a total amount of up to 100 million dollars.
老虎证券2026-03-24 21:32:33
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
Finviz2026-03-26 12:03:47
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Finviz2026-03-18 12:03:49
Cingulate Inc has submitted a prospectus supplement to the U.S. Securities and Exchange Commission, planning to conduct a market offering and sell common shares in phases for a total amount of up to 100 million dollars.
老虎证券2026-03-24 21:32:33
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
Finviz2026-03-26 12:03:47




